Physical and laboratory characteristics of heterozygote carriers of the Fanconi aplasia gene
- PMID: 2267925
- DOI: 10.1111/j.1651-2227.1990.tb11385.x
Physical and laboratory characteristics of heterozygote carriers of the Fanconi aplasia gene
Abstract
Fanconi anaemia (FA) is a recessively inherited disorder associated with a typical physical appearance and a spectrum of clinical and laboratory characteristics. Parental heterozygotes of FA patients are superficially normal in appearance and lack overt laboratory abnormalities. Furthermore, they are indistinguishable from normal subjects on chromosome analysis. In order to determine if any of the clinical or laboratory abnormalities seen in FA patients were detectable to a lesser degree in heterozygotes, we carried out detailed skeletal measurement and laboratory investigation on 16 obligate FA heterozygotes and compared the results with 40 normal control subjects. Skeletal proportions in FA heterozygotes showed significant differences from normal subjects in the ratio of the height to the inter-acromial distance (p less than 0.001), and in having significantly shorter forearms (p less than 0.05). Apart from two patients with presumed iron deficiency, haemoglobin levels were normal, but three patients showed neutropenia (less than 1.5 X 10(9)/l). Foetal haemoglobin measurements were significantly higher (p less than 0.01) and natural killer cell subsets lower (p less than 0.05) in heterozygotes. Significantly reduced mitogenetic responses to phytohaemagglutinin and interleukin-2 of peripheral blood lymphocytes in heterozygotes was also demonstrated. These results suggest that heterozygotes show minor physical and haematological abnormalities consistent with partial expression of the Fanconi gene in the heterozygote.
Similar articles
-
Body proportions in Fanconi anemia heterozygotes.Indian J Pediatr. 2000 Nov;67(11):797-801. doi: 10.1007/BF02726221. Indian J Pediatr. 2000. PMID: 11216377
-
Cytogenetic differentiation of Fanconi anemia, "idiopathic" aplastic anemia, and Fanconi anemia heterozygotes.Am J Med Genet. 1983 Jun;15(2):211-23. doi: 10.1002/ajmg.1320150205. Am J Med Genet. 1983. PMID: 6410915
-
Cytogenetic sensitivity of G0 lymphocytes of Fanconi anemia patients and obligate carriers to mitomycin C and ionizing radiation.Cytogenet Genome Res. 2007;119(3-4):191-5. doi: 10.1159/000112060. Epub 2008 Feb 1. Cytogenet Genome Res. 2007. PMID: 18253028
-
[Fanconi's anemia: in vitro tests for the individualization of heterozygotes].G Ital Med Lav. 1986 May-Jul;8(3-4):133-8. G Ital Med Lav. 1986. PMID: 3330716 Review. Italian.
-
Fanconi anaemia research: current status and prospects.Eur J Cancer. 1995;31A(2):268-72. doi: 10.1016/0959-8049(94)00485-n. Eur J Cancer. 1995. PMID: 7718336 Review.
Cited by
-
Body proportions in Fanconi anemia heterozygotes.Indian J Pediatr. 2000 Nov;67(11):797-801. doi: 10.1007/BF02726221. Indian J Pediatr. 2000. PMID: 11216377
-
Impaired immune function in children and adults with Fanconi anemia.Pediatr Blood Cancer. 2017 Nov;64(11):10.1002/pbc.26599. doi: 10.1002/pbc.26599. Epub 2017 May 30. Pediatr Blood Cancer. 2017. PMID: 28557197 Free PMC article.
-
Risk of Human Papillomavirus Infection in Cancer-Prone Individuals: What We Know.Viruses. 2018 Jan 20;10(1):47. doi: 10.3390/v10010047. Viruses. 2018. PMID: 29361695 Free PMC article. Review.
-
Impaired immune function in children with Fanconi anaemia.Br J Haematol. 2011 Jul;154(2):234-40. doi: 10.1111/j.1365-2141.2011.08721.x. Epub 2011 May 4. Br J Haematol. 2011. PMID: 21542827 Free PMC article.